Consultation opens on antenatal and newborn screening for fragile X syndrome
The UK NSC has opened a consultation on the evidence relating to antenatal and newborn screening for Fragile X syndrome.
The UK NSC has opened a consultation on the evidence relating to antenatal and newborn screening for Fragile X syndrome.
The UK NSC has opened a public consultation on evidence relation to population screening for bladder cancer.
The UK NSC has opened a consultation on evidence relating to antenatal and newborn screening for cytomegalovirus (CMV).
The UK National Screening Committee (UK NSC) has opened a consultation on evidence relating to population screening for antenatal and postnatal mental health conditions.
The UK NSC is holding its next seminar on 1 December, looking at how to assess the effectiveness of screening programmes.
Members of the UK NSC Secretariat joined experts from the Netherlands, Denmark, Sweden, Iceland, Norway, and the Republic of Ireland at the latest Nordic Screening Network meeting.
The UK National Screening Committee is hosting a roundtable information-sharing event on new technologies relating to cervical screening tests.
Paper explores the challenges, opportunities and practical approaches when developing mathematical models to support policy decisions in newborn blood spot screening.
Analysis of UK NSC consultation responses published in journal article.
Newborn screening for hereditary tyrosinaemia type 1 (HT1) has been implemented in England.